Alnylam Pharmaceuticals, Inc. · Brief

Next report

102 days

Feb 11 · before openest.Q4 FY26

Expected move

No implied move.

8 reportsHistory

—≥ implied

Jan 13 '25—▲+8.53%—

Jul 31 '25—▲+15.43%—

Oct 30 '25—▼−6.65%—

Jan 12 '26—▼−6.87%—

Feb 12 '26—▼−4.28%—

Q1 FY26—▲+2.76%—

Q2 FY26—▼−28.31%—

Q3 FY26±11.1%▼−25.13%×2.27

quarterimplied−30%0+30%realized×

Q3 FY26±11.1%▼−25.13%×2.27

Q2 FY26—▼−28.31%—

Q1 FY26—▲+2.76%—

Feb '26—▼−4.28%—

Jan '26—▼−6.87%—

Oct '25—▼−6.65%—

2 older reports

Jul '25—▲+15.43%—

Jan '25—▲+8.53%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Feb 11 report · est.

—

ALNY report session

Suppliers 1

× = co-movement · max 501dSource: SEC filings · market data

Oct 29haltTrading halt: 09:35 ET, resumed 09:40 ET.Source

Oct 15impliedImplied move: ±12.4% into Oct 29 earnings (Oct 15 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.